Medicine and Dentistry
Heart Transplantation
100%
Left Ventricular Assist Device
63%
Transplantation
53%
Ventricular Assist Device
53%
Regional Perfusion
43%
Extracorporeal Membrane Oxygenation
40%
Assisted Circulation
33%
Allograft
30%
Brain Death
26%
Lung Transplantation
26%
Organ Donor
23%
Graft Failure
21%
Hazard Ratio
20%
Aortic Valve Replacement
19%
Aortic Valve
19%
Heart Failure
19%
Surgical Technique
16%
Heart Surgery
16%
Mitral Valve Repair
15%
Surgery
14%
Thrombosis
14%
Heart Graft
14%
Health Care Cost
13%
Adverse Event
13%
Atrial Septal Defect
11%
Mitral Valve Disease
11%
Primary Graft Dysfunction
11%
Dilated Cardiomyopathy
10%
Anticoagulation
10%
Long Term Survival
10%
Cannula
10%
Infection
10%
Aortic Valve Surgery
9%
Systolic Function
9%
Surgeon
9%
Hospital Mortality
9%
Echocardiography
9%
Device Infection
8%
Machine Perfusion
8%
Hemodynamic
8%
Implant
8%
Contraindication
7%
Thrombophilia
7%
Hodgkin's Lymphoma
7%
Endothelial Microparticle
7%
Aortic Valve Disease
7%
Blood Transfusion
7%
Ectopic Thyroid Gland
7%
Valve Replacement
7%
Sarcoma
7%
Keyphrases
Donation after Circulatory Death
23%
Left Ventricular Assist Device
19%
Heart Transplant Outcomes
15%
Transplantation
12%
Heart Transplantation
12%
Hazard Ratio
11%
Ventricular Assist Device
10%
Aortic Valve Replacement
10%
Lung Transplantation
9%
Transplant Outcomes
8%
Circulating Endothelial Microparticles
7%
Temporary Mechanical Circulatory Support
7%
Left Ventricle Assist Device
7%
Sternal Complications
7%
Single Surgeon
7%
Surgery-valve
7%
In Situ Recovery
7%
DCD Heart
7%
Pump Thrombosis
7%
HeartWare Ventricular Assist Device
7%
Aortic Valve Opening
7%
Controlled Donation after Circulatory Death
7%
Aortic Valve Surgery
7%
Temporary Right Ventricular Assist Device
7%
Ectopic Thyroid
7%
LVAD Implantation
7%
Allosensitization
7%
Rejection Surveillance
7%
Struma
7%
Waitlist Outcomes
7%
Paracorporeal
7%
Mitral Valve Repair
7%
Cardiac Transplantation
7%
Novel Management
7%
Large Volume
7%
Anticoagulation Treatment
7%
Mechanical Cardiac Support
7%
Mechanical Circulatory Support Device
7%
Intestinal Bleeding
7%
Transmyocardial Laser Revascularization
7%
IgG4-related Disease (IgG4-RD)
7%
Donor Intervention
7%
Cardiac Sarcoma
7%
SherpaPak
7%
Single-center Analysis
7%
Surgeon Volume
7%
Ventricular Septal Defect Repair
7%
Angiotensin II Type 1 Receptor Antibody
7%
Donor Variables
7%
National Experience
7%